目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 28)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS
1.4 MARKET SCOPE
1.4.1 MARKETS COVERED
1.4.2 REGIONS COVERED
1.4.3 YEARS CONSIDERED
1.4.4 CURRENCY CONSIDERED
1.5 RESEARCH LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT: UROLOGY DEVICES MARKET

2 RESEARCH METHODOLOGY (Page No. - 34)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
2.1.2.4 Breakdown of primary interviews
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 4 COMPANY REVENUE ESTIMATION IN UROLOGY DEVICES INDUSTRY
2.2.1.1 Presentations of companies and primary interviews
2.2.1.2 Growth forecast
2.2.1.3 CAGR projections
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.2.2 TOP-DOWN APPROACH
FIGURE 6 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 GROWTH RATE ASSUMPTIONS
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: MARKET
2.8 IMPACT OF ECONOMIC RECESSION ON MARKET

3 EXECUTIVE SUMMARY (Page No. - 47)
FIGURE 8 UROLOGY DEVICES MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 9 UROLOGY DEVICES INDUSTRY, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 10 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 11 MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 50)
4.1 UROLOGY DEVICES MARKET OVERVIEW
FIGURE 12 RISING PREVALENCE OF UROLOGICAL DISEASES TO DRIVE MARKET
4.2 UROLOGY DEVICES INDUSTRY, BY PRODUCT, 2023 VS. 2028
FIGURE 13 INSTRUMENTS TO DOMINATE MARKET DURING FORECAST PERIOD
4.3 MARKET, BY APPLICATION, 2023 VS. 2028
FIGURE 14 KIDNEY DISEASES TO COMMAND LARGEST MARKET SHARE IN 2028
4.4 MARKET, BY END USER, 2023 VS. 2028
FIGURE 15 HOSPITALS, ASCS, AND CLINICS SEGMENT TO DOMINATE MARKET DURING STUDY PERIOD
4.5 REGIONAL GROWTH OPPORTUNITIES: MARKET
FIGURE 16 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD

5 MARKET OVERVIEW (Page No. - 53)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: UROLOGY DEVICES MARKET
5.2.1 DRIVERS
5.2.1.1 Rising incidence of urological diseases
TABLE 2 GLOBAL INCIDENCE OF UROLOGICAL CANCER, 2020
TABLE 3 ESTIMATED NEW UROLOGICAL CANCER CASES AND DEATHS IN US, 2022
5.2.1.2 Growing preference for minimally invasive procedures
TABLE 4 ESTIMATED MARKET SIZE FOR MINIMALLY INVASIVE SURGICAL PROCEDURES, 2021-2030
5.2.1.3 Rising focus on R&D and product launches
5.2.1.4 Growing number of hospitals and surgical centers
5.2.2 RESTRAINTS
5.2.2.1 High degree of consolidation among key players
5.2.3 OPPORTUNITIES
5.2.3.1 Potential growth opportunities in emerging economies
5.2.3.2 Technological advancements
5.2.4 CHALLENGES
5.2.4.1 Increasing number of product recalls by key players
TABLE 5 LIST OF PRODUCT RECALLS BY KEY PLAYERS, 2021-2023
5.2.4.2 Shortage of skilled urologists
5.3 PRICING ANALYSIS
TABLE 6 INDICATIVE PRICING FOR UROLOGY DEVICES (IN USD)
5.3.1 AVERAGE SELLING PRICE OF UROLOGY DEVICES
TABLE 7 AVERAGE SELLING PRICE OF UROLOGY DEVICES, BY REGION
5.4 VALUE CHAIN ANALYSIS
FIGURE 18 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 19 SUPPLY CHAIN ANALYSIS
5.6 PATENT ANALYSIS
FIGURE 20 PATENT ANALYSIS FOR UROLOGY DEVICES, JANUARY 2013-DECEMBER 2022
TABLE 8 LIST OF MAJOR PATENTS, 2020-2022
5.7 TRADE ANALYSIS
5.7.1 TRADE ANALYSIS FOR UROLOGY DEVICES
TABLE 9 IMPORT DATA FOR DIALYSIS INSTRUMENTS, BY COUNTRY, 2018-2022 (USD MILLION)
TABLE 10 EXPORT DATA FOR DIALYSIS INSTRUMENTS, BY COUNTRY, 2018-2022 (USD MILLION)
5.8 ECOSYSTEM MARKET/MAP
FIGURE 21 ECOSYSTEM MARKET MAP
TABLE 11 ROLE IN ECOSYSTEM
5.9 PORTER’S FIVE FORCES ANALYSIS
TABLE 12 PORTER’S FIVE FORCES
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF SUPPLIERS
5.9.4 BARGAINING POWER OF BUYERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 PESTLE ANALYSIS
5.11 REGULATORY ANALYSIS
TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.1 NORTH AMERICA
5.11.1.1 US
5.11.1.2 Canada
5.11.2 EUROPE
5.11.3 ASIA PACIFIC
5.11.3.1 China
5.11.3.2 Japan
5.11.3.3 India
5.11.4 LATIN AMERICA
5.11.4.1 Brazil
5.11.4.2 Mexico
5.11.5 MIDDLE EAST
5.11.6 AFRICA
5.12 KEY CONFERENCES & EVENTS
TABLE 17 DETAILED LIST OF KEY CONFERENCES & EVENTS IN 2023-2024
5.13 TECHNOLOGY ANALYSIS
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 22 REVENUE SHIFT IN MARKET
5.15 KEY STAKEHOLDERS & BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR UROLOGY DEVICES
TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR UROLOGY DEVICES (%)
5.15.2 BUYING CRITERIA
FIGURE 24 KEY BUYING CRITERIA FOR END USERS OF UROLOGY DEVICES
TABLE 19 KEY BUYING CRITERIA, BY END USER
5.16 CASE STUDY ANALYSIS
5.16.1 CASE STUDY: IDENTIFICATION OF FACTORS FOR SURGICAL ADVANCEMENTS

6 UROLOGY DEVICES MARKET, BY PRODUCT (Page No. - 81)
6.1 INTRODUCTION
TABLE 20 UROLOGY DEVICES INDUSTRY, BY PRODUCT, 2021-2028 (USD MILLION)
6.1.1 PRIMARY NOTES
6.1.1.1 Key industry insights
6.2 INSTRUMENTS
TABLE 21 MARKET FOR INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION)
TABLE 22 MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
6.2.1 DIALYSIS DEVICES
TABLE 23 DIALYSIS DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 24 DIALYSIS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
6.2.1.1 Hemodialysis devices
6.2.1.1.1 Technological advancements and increased need for home dialysis to drive segment
TABLE 25 HEMODIALYSIS DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
6.2.1.2 Peritoneal dialysis devices
6.2.1.2.1 Cost-effectiveness and lesser time consumption to drive segment
TABLE 26 PERITONEAL DIALYSIS DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
6.2.2 ENDOSCOPES
TABLE 27 ENDOSCOPES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 28 ENDOSCOPES MARKET, BY TYPE, 2021-2028 (USD MILLION)
6.2.2.1 Laparoscopes
6.2.2.1.1 Lower surgical-site infection and faster recovery rates to drive segment
TABLE 29 LAPAROSCOPES MARKET, BY REGION, 2021-2028 (USD MILLION)
6.2.2.2 Ureteroscopes
6.2.2.2.1 Technological advancements and development of advanced ureteroscopy for kidney stones to drive segment
TABLE 30 URETEROSCOPES MARKET, BY REGION, 2021-2028 (USD MILLION)
6.2.2.3 Nephroscopes
6.2.2.3.1 Increasing incidence of chronic kidney diseases to drive segment
TABLE 31 NEPHROSCOPES MARKET, BY REGION, 2021-2028 (USD MILLION)
6.2.2.4 Resectoscopes
6.2.2.4.1 High prevalence of prostate, kidney, and bladder cancers to drive segment
TABLE 32 RESECTOSCOPES MARKET, BY REGION, 2021-2028 (USD MILLION)
6.2.2.5 Cystoscopes
6.2.2.5.1 Increasing prevalence of urological cancers to drive segment
TABLE 33 CYSTOSCOPES MARKET, BY REGION, 2021-2028 (USD MILLION)
6.2.3 LASER & LITHOTRIPSY DEVICES
6.2.3.1 Increasing prevalence of kidney stones to drive segment
TABLE 34 LASER & LITHOTRIPSY DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
6.2.4 ENDOVISION & IMAGING SYSTEMS
6.2.4.1 Need for high-resolution images for better observation of body cavities and organs to drive segment
TABLE 35 ENDOVISION & IMAGING SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
6.2.5 ROBOTIC SYSTEMS
6.2.5.1 Increasing public-private collaborations for research on minimally-invasive surgeries to drive segment
TABLE 36 ROBOTIC SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
6.2.6 INSUFFLATORS
6.2.6.1 Increasing number of laparoscopic surgeries to drive segment
TABLE 37 INSUFFLATORS MARKET, BY REGION, 2021-2028 (USD MILLION)
6.2.7 ENDOSCOPY FLUID MANAGEMENT SYSTEMS
6.2.7.1 Ease of use, improved safety, and lesser medical expense to drive segment
TABLE 38 ENDOSCOPY FLUID MANAGEMENT SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
6.2.8 URODYNAMIC SYSTEMS
6.2.8.1 Growing patient pool in emerging economies to drive segment
TABLE 39 URODYNAMIC SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
6.2.9 OTHER INSTRUMENTS
TABLE 40 OTHER INSTRUMENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
6.3 CONSUMABLES & ACCESSORIES
TABLE 41 MARKET FOR CONSUMABLES & ACCESSORIES, BY REGION, 2021-2028 (USD MILLION)
TABLE 42 MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021-2028 (USD MILLION)
6.3.1 DIALYSIS CONSUMABLES
6.3.1.1 Increasing use of dialyzers and rising number of repeat purchases to drive segment
TABLE 43 DIALYSIS CONSUMABLES MARKET, BY REGION, 2021-2028 (USD MILLION)
6.3.2 CATHETERS
6.3.2.1 High prevalence of urinary incontinence and increased number of surgical procedures to drive segment
TABLE 44 CATHETERS MARKET, BY REGION, 2021-2028 (USD MILLION)
6.3.3 GUIDEWIRES
6.3.3.1 Development of next-generation hybrid guidewires and increased applications in endoscopy to drive segment
TABLE 45 GUIDEWIRES MARKET, BY REGION, 2021-2028 (USD MILLION)
6.3.4 RETRIEVAL DEVICES & EXTRACTORS
6.3.4.1 Growing number of kidney stone removal surgeries to drive market
TABLE 46 RETRIEVAL DEVICES & EXTRACTORS MARKET, BY REGION, 2021-2028 (USD MILLION)
6.3.5 SURGICAL DISSECTORS, FORCEPS, AND NEEDLE HOLDERS
6.3.5.1 Growing number of urology procedures and increasing prevalence of chronic kidney diseases to drive segment
TABLE 47 SURGICAL DISSECTORS, FORCEPS, AND NEEDLE HOLDERS MARKET, BY REGION, 2021-2028 (USD MILLION)
6.3.6 DILATOR SETS & URETHRAL ACCESS SHEATHS
6.3.6.1 Growing demand for effective endoscopic management of ureteral and renal calculi to drive segment
TABLE 48 DILATOR SETS & URETHRAL ACCESS SHEATHS MARKET, BY REGION, 2021-2028 (USD MILLION)
6.3.7 STENTS & IMPLANTS
6.3.7.1 Growing prevalence of kidney-related disorders and erectile dysfunction to drive segment
TABLE 49 STENTS & IMPLANTS MARKET, BY REGION, 2021-2028 (USD MILLION
6.3.8 BIOPSY DEVICES
6.3.8.1 High incidence of prostate cancer among male geriatric population to drive segment
TABLE 50 BIOPSY DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
6.3.9 TUBES & DISTAL ATTACHMENTS
6.3.9.1 Growing demand for endoscopy and colonoscopy procedures to drive market
TABLE 51 TUBES & DISTAL ATTACHMENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
6.3.10 DRAINAGE BAGS
6.3.10.1 Increased risk of urinary tract infections to limit market
TABLE 52 DRAINAGE BAGS MARKET, BY REGION, 2021-2028 (USD MILLION)
6.3.11 OTHER CONSUMABLES & ACCESSORIES
TABLE 53 OTHER CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2021-2028 (USD MILLION)

7 UROLOGY DEVICES MARKET, BY APPLICATION (Page No. - 115)
7.1 INTRODUCTION
TABLE 54 UROLOGY DEVICES INDUSTRY, BY APPLICATION, 2021-2028 (USD MILLION)
7.2 KIDNEY DISEASES
7.2.1 GROWING PREVALENCE OF DIABETES AND HYPERTENSION TO DRIVE MARKET
TABLE 55 MARKET FOR KIDNEY DISEASES, BY REGION, 2021-2028 (USD MILLION)
7.3 UROLOGICAL CANCER
7.3.1 RISING PREVALENCE OF SURGERIES FOR UROLOGICAL CANCER TREATMENT TO DRIVE MARKET
TABLE 56 MARKET FOR UROLOGICAL CANCER, BY REGION, 2021-2028 (USD MILLION)
7.4 PELVIC ORGAN PROLAPSE
7.4.1 HIGH COSTS OF SURGERIES AND LACK OF EFFECTIVE PELVIC ORGAN PROLAPSE TREATMENT TO LIMIT MARKET
TABLE 57 MARKET FOR PELVIC ORGAN PROLAPSE, BY REGION, 2021-2028 (USD MILLION)
7.5 BENIGN PROSTATIC HYPERPLASIA
7.5.1 GROWING GERIATRIC POPULATION AND IMPROVING TREATMENT OPTIONS TO DRIVE MARKET
TABLE 58 MARKET FOR BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2021-2028 (USD MILLION)
7.6 URINARY INCONTINENCE
7.6.1 GROWING PREVALENCE OF URINARY INCONTINENCE IN OLDER POPULATION TO DRIVE MARKET
TABLE 59 ESTIMATED PREVALENCE FOR TYPES OF URINARY INCONTINENCE, 2022
TABLE 60 MARKET FOR BENIGN URINARY INCONTINENCE, BY REGION, 2021-2028 (USD MILLION)
7.7 ERECTILE DYSFUNCTION
7.7.1 RISING PREVALENCE OF PROSTATE CANCER TO DRIVE MARKET
TABLE 61 MARKET FOR ERECTILE DYSFUNCTION, BY REGION, 2021-2028 (USD MILLION)
7.8 URINARY STONES
7.8.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE MARKET
TABLE 62 MARKET FOR URINARY STONES, BY REGION, 2021-2028 (USD MILLION)
7.9 OTHER APPLICATIONS
TABLE 63 MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)

8 UROLOGY DEVICES MARKET, BY END USER (Page No. - 126)
8.1 INTRODUCTION
TABLE 64 UROLOGY DEVICES INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
8.2 HOSPITALS, ASCS, AND CLINICS
8.2.1 HOSPITALS, ASCS, AND CLINICS SEGMENT TO COMMAND LARGEST MARKET SHARE DURING STUDY PERIOD
TABLE 65 MARKET FOR HOSPITALS, ASCS, AND CLINICS, BY REGION, 2021-2028 (USD MILLION)
8.3 DIALYSIS CENTERS
8.3.1 INCREASED DEMAND FOR ADVANCED DIALYSIS PRODUCTS AND FACILITIES TO DRIVE MARKET
TABLE 66 NUMBER OF DIALYSIS CENTERS IN US, BY COMPANY, 2022
TABLE 67 MARKET FOR DIALYSIS CENTERS, BY REGION, 2021-2028 (USD MILLION)
8.4 HOME CARE SETTINGS
8.4.1 UNAVAILABILITY OF DIALYSIS CENTERS IN EMERGING ECONOMIES TO DRIVE MARKET
TABLE 68 MARKET FOR HOME CARE SETTINGS, BY REGION, 2021-2028 (USD MILLION)

9 UROLOGY DEVICES MARKET, BY REGION (Page No. - 132)
9.1 INTRODUCTION
TABLE 69 UROLOGY DEVICES INDUSTRY, BY REGION, 2021-2028 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 25 NORTH AMERICA: UROLOGY DEVICES MARKET SNAPSHOT
TABLE 70 NORTH AMERICA: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 71 NORTH AMERICA: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 72 NORTH AMERICA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 73 NORTH AMERICA: UROLOGY DEVICES INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
9.2.1 NORTH AMERICA: RECESSION IMPACT
9.2.2 US
9.2.2.1 US to dominate North American urology devices market during forecast period
TABLE 74 US: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 75 US: MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 76 US: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 77 US: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Rising prevalence of urological cancers and diabetes to drive market
TABLE 78 CANADA: UROLOGY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 79 CANADA: MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 80 CANADA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 81 CANADA: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.3 EUROPE
TABLE 82 EUROPE: UROLOGY DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 83 EUROPE: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 84 EUROPE: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 85 EUROPE: UROLOGY DEVICES INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
9.3.1 EUROPE: RECESSION IMPACT
9.3.2 GERMANY
9.3.2.1 Rising geriatric population and growing incidence of urological cancers to drive market
TABLE 86 GERMANY: UROLOGY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 87 GERMANY: MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 88 GERMANY: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 89 GERMANY: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.3.3 UK
9.3.3.1 Rising incidence of kidney diseases and better reimbursement policies for dialysis to drive market
TABLE 90 UK: UROLOGY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 91 UK: MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 92 UK: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 93 UK: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.3.4 FRANCE
9.3.4.1 Favorable government initiatives and rising number of surgical procedures to drive market
TABLE 94 FRANCE: UROLOGY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 95 FRANCE: MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 96 FRANCE: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 97 FRANCE: UROLOGY DEVICES INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Increasing cases of chronic kidney diseases and rising geriatric population to drive market
TABLE 98 ITALY: UROLOGY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 99 ITALY: MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 100 ITALY: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 101 ITALY: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 Increasing government initiatives and healthcare funding to drive market
TABLE 102 SPAIN: UROLOGY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 103 SPAIN: MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 104 SPAIN: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 105 SPAIN: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 106 REST OF EUROPE: UROLOGY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 107 REST OF EUROPE: MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 108 REST OF EUROPE: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 109 REST OF EUROPE: UROLOGY DEVICES INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 26 ASIA PACIFIC: UROLOGY DEVICES MARKET SNAPSHOT
TABLE 110 ASIA PACIFIC: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 111 ASIA PACIFIC: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 112 ASIA PACIFIC: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 113 ASIA PACIFIC: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.4.1 ASIA PACIFIC: RECESSION IMPACT
9.4.2 CHINA
9.4.2.1 Improving healthcare infrastructure and rising disposable income of middle-class population to drive market
TABLE 114 CHINA: UROLOGY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 115 CHINA: MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 116 CHINA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 117 CHINA: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.4.3 JAPAN
9.4.3.1 Well-established healthcare system and large geriatric population to drive market
TABLE 118 JAPAN: UROLOGY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 119 JAPAN: MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 120 JAPAN: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 121 JAPAN: UROLOGY DEVICES INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Improvement in healthcare infrastructure and presence of large patient pool to drive market
TABLE 122 INDIA: UROLOGY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 123 INDIA: MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 124 INDIA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 125 INDIA: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 126 REST OF ASIA PACIFIC: UROLOGY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 127 REST OF ASIA PACIFIC: MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 128 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 129 REST OF ASIA PACIFIC: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 RISING PREVALENCE OF CHRONIC DISEASES AND GROWING PATIENT POOL TO DRIVE MARKET
TABLE 130 LATIN AMERICA: UROLOGY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 131 LATIN AMERICA: MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 132 LATIN AMERICA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 133 LATIN AMERICA: UROLOGY DEVICES INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
9.5.2 LATIN AMERICA: RECESSION IMPACT
9.6 MIDDLE EAST & AFRICA
9.6.1 INCREASING HEALTHCARE EXPENDITURE AND IMPROVING HEALTHCARE SYSTEM TO DRIVE MARKET
TABLE 134 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 135 MIDDLE EAST & AFRICA: MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 136 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 137 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT

10 COMPETITIVE LANDSCAPE (Page No. - 181)
10.1 OVERVIEW
10.2 KEY STRATEGIES/RIGHT TO WIN
TABLE 138 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN UROLOGY DEVICES MARKET
10.3 REVENUE SHARE ANALYSIS
FIGURE 27 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS
10.4 MARKET SHARE ANALYSIS
FIGURE 28 UROLOGY DEVICES INDUSTRY SHARE, BY KEY PLAYER, 2022
TABLE 139 DEGREE OF COMPETITION: UROLOGY DEVICES INDUSTRY
10.5 COMPANY EVALUATION MATRIX
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE29 COMPANY EVALUATION MATRIX, 2022
10.5.5 COMPANY FOOTPRINT
FIGURE30 PRODUCT AND REGIONAL FOOTPRINT
TABLE 140 PRODUCT FOOTPRINT
TABLE 141 REGIONAL FOOTPRINT
10.6 SME/START-UP EVALUATION MATRIX
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
FIGURE31 START-UP/SME EVALUATION MATRIX, 2022
10.6.5 COMPETITIVE BENCHMARKING
TABLE 142 COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 143 DETAILED LIST OF KEY START-UPS/SMES
10.7 COMPETITIVE SCENARIOS AND TRENDS
10.7.1 KEY PRODUCT LAUNCHES & APPROVALS
TABLE 144 KEY PRODUCT LAUNCHES & APPROVALS, JANUARY 2020-OCTOBER 2023
10.7.2 KEY DEALS
TABLE 145 KEY DEALS, JANUARY 2020-OCTOBER 2023
10.7.3 OTHER KEY DEVELOPMENTS
TABLE 146 OTHER KEY DEVELOPMENTS, JANUARY 2020-OCTOBER 2023

11 COMPANY PROFILES (Page No. - 195)
(Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1 KEY PLAYERS
11.1.1 FRESENIUS MEDICAL CARE AG & CO. KGAA
TABLE 147 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY OVERVIEW
FIGURE32 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT (2022)
11.1.2 BAXTER INTERNATIONAL, INC.
TABLE 148 BAXTER INTERNATIONAL, INC.: COMPANY OVERVIEW
FIGURE33 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2022)
11.1.3 BOSTON SCIENTIFIC CORPORATION
TABLE 149 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
FIGURE34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
11.1.4 BECTON, DICKINSON AND COMPANY
TABLE 150 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
FIGURE35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
11.1.5 B. BRAUN MELSUNGEN AG
TABLE 151 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW
FIGURE36 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022)
11.1.6 CARDINAL HEALTH
TABLE 152 CARDINAL HEALTH: COMPANY OVERVIEW
FIGURE37 CARDINAL HEALTH: COMPANY SNAPSHOT (2022)
11.1.7 OLYMPUS CORPORATION
TABLE 153 OLYMPUS CORPORATION: COMPANY OVERVIEW
FIGURE38 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
11.1.8 INTUITIVE SURGICAL
TABLE 154 INTUITIVE SURGICAL: COMPANY OVERVIEW
FIGURE39 INTUITIVE SURGICAL: COMPANY SNAPSHOT (2022)
11.1.9 COLOPLAST A/S
TABLE 155 COLOPLAST A/S: COMPANY OVERVIEW
FIGURE40 COLOPLAST A/S: COMPANY SNAPSHOT (2022)
11.1.10 STRYKER CORPORATION
TABLE 156 STRYKER CORPORATION: COMPANY OVERVIEW
FIGURE41 STRYKER CORPORATION: COMPANY SNAPSHOT (2022)
11.1.11 TELEFLEX INCORPORATED
TABLE 157 TELEFLEX INCORPORATED: COMPANY OVERVIEW
FIGURE42 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022)
11.1.12 CONVATEC GROUP PLC
TABLE 158 CONVATEC GROUP PLC: COMPANY OVERVIEW
FIGURE43 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2022)
11.1.13 MEDTRONIC PLC
TABLE 159 MEDTRONIC PLC: COMPANY OVERVIEW
FIGURE44 MEDTRONIC PLC: COMPANY SNAPSHOT (2022)
11.2 OTHER PLAYERS
11.2.1 KARL STORZ
11.2.2 COOK MEDICAL
11.2.3 RICHARD WOLF GMBH
11.2.4 COMPACTCATH
11.2.5 DORNIER MEDTECH
11.2.6 NIKKISO CO., LTD.
11.2.7 DIALIFE SA
11.2.8 ERBE VISION
11.2.9 WELL LEAD MEDICAL CO., LTD.
11.2.10 ROCAMED
11.2.11 ENDOMED SYSTEMS GMBH
11.2.12 AMSINO INTERNATIONAL, INC.
11.2.13 MEDISPEC
11.2.14 MEDICAL TECHNOLOGIES OF GEORGIA
11.2.15 VIMEX SP. Z O. O.
11.2.16 BALTON SP. Z O.O.
11.2.17 HUNTER UROLOGY (PART OF OPTIMUM MEDICAL GROUP)
11.2.18 RIBBEL INTERNATIONAL LIMITED
*Details on Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 268)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS